From theory to breakthrough.
Our turning point: AbstimX™
Founded in 2003 by immunologist Dr. Geoffrey Hoffmann, Network Immunology was built on decades of academic research and a bold insight: the immune system functions as a network, not a linear chain of reactions. His discovery of symmetrical immune network theory breathed new life into an overlooked field—and set the stage for today’s breakthroughs.
Ea In collaboration with Dr. Reginald Gorczynski, we translated theory into practice, developing AbstimX™ and proving its effectiveness in preclinical studies across inflammatory diseases.
From research to real-world impact.
Our research includes successful studies in peanut allergy, egg allergy, colitis, and even inflammatory cancer. Five peer-reviewed papers back our approach and highlight the platform’s broad applicability. These results laid the groundwork for clinical development.
In 2024, we launched our first canine clinical trial in partnership with the University of Florida. This is just the beginning. With new partnerships forming and human trials in development, we’re entering a pivotal stage in reshaping immune care.
From academic theory to real-world impact, Network Immunology is redefining how we approach chronic immune conditions, through innovative science, strong partnerships, and a commitment to changing lives, both human and animal.